WASHINGTON, D.C.— The American Institute for Medical and Biological Engineering (AIMBE) has announced the pending induction of Peng Wang, Ph.D., President of R&D, , Yabao Pharmaceutical Group, to its College of Fellows. Dr. Wang was nominated, reviewed, and elected by peers and members of the College of Fellows For pioneering global collaborative innovation between West and China to develop chemical and biological new drugs for unmet medical needs..